Articles Posted in FTC Antitrust Highlights

On February 26, 2009, the Federal Trade Commission (“FTC”) intervened in Lubrizol Corporation’s (“Lubrizol”) 2007 acquisition of oxidate assets from its rival The Lockhart Company (“Lockhart”). On February 7, 2007, Lubrizol signed an asset purchase agreement with Lockhart to purchase Lockhart’s oxidate assets. Oxidate assets are chemical additives that are used to make rust preventives.…

On January 29, 2009, Getinge AB (“Getinge”) settled charges with the Federal Trade Commission (“FTC”) in order for its $865 million acquisition of rival Datascope Corporation (“Datascope”) to proceed. The FTC believed that the proposed acquisition violated federal antitrust laws. Datascope is required to divest its endoscopic vessel harvesting (“EVH”) product line to an FTC…

On January 23, 2009, Dow Chemical Company (“Dow”) settled charges with the Federal Trade Commission (“FTC”) in order for its $18.8 million acquisition of rival Rohm & Haas Company (“R&H”) to proceed. Dow agreed to sell a range of assets to an FTC approved buyer and put in place mechanisms to ensure Dow will not…

On January 14, 2009, the Federal Trade Commission (“FTC”) filed a suit to block the proposed $540 million assets and interest acquisition of Pavestone Co. (“Pavestone”) by rival Oldcastle Architectural, Inc. (“Oldcastle”) because it would reduce competition in the manufacture and sale of drycast concrete hardscapes.Both companies manufacture and sell drycast concrete hardscape products, which…

On December 29, 2008, the Federal Trade Commission (“FTC”) required a divestiture to resolve antitrust concerns with King Pharmaceuticals, Inc.’s (“King”) $1.6 billion acquisition of Alpharma, Inc. (“Alpharma”). To remedy the situation, the FTC is requiring King to divest Alpharma’s brand Kadian, an oral long-acting opioid (“LAO”) analgesic drug, to Actavis, one of the world’s…

On December 19, 2008, Teva Pharmaceuticals Industries Ltd.’s settled charges that its proposed $8.9 billion acquisition of rival generic drug maker Barr Pharmaceuticals Inc. would be anticompetitive. The consent order required Teva and Barr to sell assets in 29 relevant markets, including generic drugs commonly used to treat acid reflux disease, various types of cancer,…

On December 15, 2008, ESL Partners (“ESL”) of Greenwich, Conn., and ZAM Holdings (“ZAM”) of New York City, two investment funds with holdings in numerous companies, will pay $525,000 and $275,000, respectively, in civil penalties for violating antitrust pre-merger notification requirements under the Hart-Scott-Rodino Act of 1976 (“HSR Act”). According to the complaint, after its…

On November 25, 2008, the FTC moved to block a merger between CCC Information Systems Inc (“CCC”), a subsidiary of CCC Holdings Inc., and Mitchell International Inc (“Mitchell”), owned by Aurora Equity Fund III LP.Both companies provide services in estimatics, electronic systems used to estimate the cost of collision repairs, and total loss valuation (“TLV”)…

On October 23, 2008, the Federal Trade Commission (“FTC”) challenged CCS Corporation’s (“CCS”) proposed $85 billion acquisition of Newpark Environmental Services (“Newpark”), a division of Newpark Resources, Inc.The FTC alleged that the proposed transaction would have combined two of only three providers of waste disposal services to the offshore oil and natural gas exploration and…

On September 2, 2008, Marian R. Bruno, the Associate Director of Management and Operations in the Federal Trade Comission’s (“FTC”) Bureau of Competition (“Bureau”), was named the Deputy Director of the Bureau of Competition. Norman Armstrong, Deputy Assistant Director of the Bureau’s Mergers IV Division, has been named Acting Deputy Director. They join Kenneth Glazer,…